NeoGenomics, Inc. Shares Outstanding (Cover Page)
NeoGenomics, Inc. (NEO) had Shares Outstanding (Cover Page) of 128.48 million shares as of 2026-07-24, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-28
- 2026-07-24: Entity Common Stock, Shares Outstanding 128.48M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 130.21M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 129.81M shares.
- 2025-10-24: Entity Common Stock, Shares Outstanding 129.39M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-24 | 128.48M shares 10-Q · filed 2026-07-28 |
| 2026-04-24 | 130.21M shares 10-Q · filed 2026-04-28 |
| 2026-02-13 | 129.81M shares 10-K · filed 2026-02-17 |
| 2025-10-24 | 129.39M shares 10-Q · filed 2025-10-28 |
| 2025-07-25 | 129.18M shares 10-Q · filed 2025-07-29 |
| 2025-04-25 | 128.69M shares 10-Q · filed 2025-04-29 |
| 2025-02-11 | 128.46M shares 10-K · filed 2025-02-18 |
| 2024-11-01 | 128.36M shares 10-Q · filed 2024-11-05 |
| 2024-07-26 | 128.16M shares 10-Q · filed 2024-07-30 |
| 2024-04-26 | 127.71M shares 10-Q · filed 2024-04-30 |
| 2024-02-13 | 127.61M shares 10-K · filed 2024-02-20 |
| 2023-11-02 | 127.47M shares 10-Q · filed 2023-11-06 |
| 2023-08-04 | 127.55M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 127.58M shares 10-Q · filed 2023-05-09 |
| 2023-02-20 | 127.46M shares 10-K · filed 2023-02-24 |
| 2022-11-04 | 126.30M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 125.80M shares 10-Q · filed 2022-08-09 |
| 2022-05-06 | 124.76M shares 10-Q · filed 2022-05-09 |
| 2022-02-21 | 124.03M shares 10-K · filed 2022-02-25 |
| 2021-11-03 | 123.12M shares 10-Q · filed 2021-11-04 |
| 2021-08-05 | 122.82M shares 10-Q · filed 2021-08-09 |
| 2021-05-04 | 117.93M shares 10-Q · filed 2021-05-06 |
| 2021-02-22 | 116.94M shares 10-K · filed 2021-02-25 |
| 2020-10-27 | 111.03M shares 10-Q · filed 2020-10-29 |
| 2020-07-28 | 110.43M shares 10-Q · filed 2020-07-31 |
| 2020-04-24 | 105.34M shares 10-Q · filed 2020-04-29 |
| 2020-02-24 | 104.83M shares 10-K · filed 2020-02-28 |
| 2019-11-08 | 104.41M shares 10-Q · filed 2019-11-13 |
| 2019-08-02 | 103.86M shares 10-Q · filed 2019-08-07 |
| 2019-05-03 | 95.34M shares 10-Q · filed 2019-05-08 |
| 2019-02-22 | 94.57M shares 10-K · filed 2019-02-26 |
| 2018-11-02 | 93.02M shares 10-Q · filed 2018-11-06 |
| 2018-08-01 | 81.64M shares 10-Q · filed 2018-08-06 |
| 2018-05-04 | 80.62M shares 10-Q · filed 2018-05-08 |
| 2018-03-05 | 80.51M shares 10-K · filed 2018-03-13 |
| 2017-11-07 | 80.41M shares 10-Q · filed 2017-11-13 |
| 2017-08-03 | 79.39M shares 10-Q · filed 2017-08-07 |
| 2017-05-04 | 79.24M shares 10-Q · filed 2017-05-09 |
| 2017-03-09 | 78.82M shares 10-K · filed 2017-03-14 |
| 2016-11-02 | 78.51M shares 10-Q · filed 2016-11-07 |
| 2016-08-03 | 77.89M shares 10-Q · filed 2016-08-05 |
| 2016-04-20 | 77.12M shares 10-Q · filed 2016-05-10 |
| 2016-03-09 | 75.86M shares 10-K · filed 2016-04-18 |
| 2015-11-02 | 60.35M shares 10-Q · filed 2015-11-06 |
| 2015-07-24 | 60.51M shares 10-Q · filed 2015-07-31 |
| 2015-05-05 | 60.37M shares 10-Q · filed 2015-05-11 |
| 2015-02-23 | 60.26M shares 10-K · filed 2015-03-03 |
| 2014-10-31 | 59.97M shares 10-Q · filed 2014-11-04 |
| 2014-07-23 | 50.17M shares 10-Q · filed 2014-07-29 |
| 2014-05-02 | 49.68M shares 10-Q · filed 2014-05-12 |
| 2014-02-18 | 49.12M shares 10-K · filed 2014-02-24 |
| 2013-10-25 | 48.97M shares 10-Q · filed 2013-10-30 |
| 2013-07-29 | 48.89M shares 10-Q · filed 2013-08-02 |
| 2013-05-06 | 48.70M shares 10-Q · filed 2013-05-13 |
| 2013-02-15 | 45.28M shares 10-K · filed 2013-02-21 |
| 2012-10-30 | 45.27M shares 10-Q · filed 2012-11-05 |
| 2012-08-02 | 45.16M shares 10-Q/A · filed 2012-08-15 |
| 2012-05-03 | 44.87M shares 10-Q · filed 2012-05-14 |
| 2012-03-08 | 44.84M shares 10-K · filed 2012-03-12 |
| 2011-10-21 | 43.24M shares 10-Q · filed 2011-10-25 |
| 2011-07-22 | 43.09M shares 10-Q/A · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |